Brussels, Belgium, March 3, 2016

Merodis, a corporate finance consulting firm, successfully executed the sale of Calxx Laboratories to MD Pharma. Drawing on its large network of contacts within the consumer healthcare industry, Merodis succeeded to complete the transaction within the very short time-frame required by the seller.

Calxx Laboratories (http://calxplus.com/) develops and commercializes OTC/OTX products in the fields of calcium supplements with attractive gallenics. These products are exclusively sold through pharmacies in Belgium under the brand CalxPlus. MD Pharma, a company recently incorporated by serial entrepreneur and pharmacist Mario Debel, is taking over Calxx Laboratories with the ambition to further increase the penetration of CalxPlus in Belgium and developing its potential internationally.

For more information, please contact:

Rodolphe Blondiau
rbl@merodis.com , +32 488 81 45 07
Dirk Marckx
dma@merodis.com , +32 495 38 17 81